KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Amid rising concerns about benzodiazepines, some patients who try to quit are suffering extreme anxiety, memory loss and ...

We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...

Executions by firing squad are permitted in five states, but the new law will make Idaho the only state in which death by ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

Nearly a third of the U.S. retail pharmacies that were open from 2010 to 2020 had shuttered by 2021, study finds.

Mallinckrodt and Endo, drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued ...

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...

AKT Trading is recalling its prepared vegetables due to botulism risk, according to the FDA. The pre-cut veggie’s packaging ...